Ken Griffin Merck & Co., Inc. Transaction History
Citadel Advisors LLC
- $550 Billion
- Q2 2025
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Merck & Co., Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 5,857,500 shares of MRK stock, worth $492 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
5,857,500
Previous 5,417,400
8.12%
Holding current value
$492 Million
Previous $486 Million
4.64%
% of portfolio
0.08%
Previous 0.1%
Shares
31 transactions
Others Institutions Holding MRK
# of Institutions
3,849Shares Held
1.96BCall Options Held
29.2MPut Options Held
30M-
Vanguard Group Inc Valley Forge, PA253MShares$21.2 Billion0.34% of portfolio
-
Black Rock Inc. New York, NY207MShares$17.4 Billion0.59% of portfolio
-
State Street Corp Boston, MA118MShares$9.94 Billion0.36% of portfolio
-
Wellington Management Group LLP Boston, MA76.9MShares$6.45 Billion1.15% of portfolio
-
Geode Capital Management, LLC Boston, MA59MShares$4.95 Billion0.34% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $213B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...